Insider · CIK 0001212645

MARCEL GEORGES ANTHONY

Reports to the SEC for 2 companies · ISELIN, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001212645

Forms 4 and 5

Insider transactions

22 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2005-02-16	PHARMOS CORPStock OptionsA Award	Director	AAward	+25K sh	—	—	25,000
2004-05-25	PHARMOS CORPM Exercise/Conversion	Director	MExercise/Conversion	+11.3K sh	$1.75	+$19.7K	11,250
2004-05-25	PHARMOS CORPM Exercise/Conversion	Director	MExercise/Conversion	+7,500 sh	$1.25	+$9,375	18,750
2004-05-25	PHARMOS CORPM Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$1.88	+$28.1K	33,750
2004-05-25	PHARMOS CORPM Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$1.90	+$19K	43,750
2004-05-25	PHARMOS CORPM Exercise/Conversion	Director	MExercise/Conversion	+6,250 sh	$1.02	+$6,375	50,000
2004-05-25	PHARMOS CORPS Sale	Director	SSale	−13.9K sh	$3.40	−$47.3K	36,095
2004-05-25	PHARMOS CORPS Sale	Director	SSale	−5,638 sh	$3.39	−$19.1K	30,457
2004-05-25	PHARMOS CORPS Sale	Director	SSale	−3,064 sh	$3.37	−$10.3K	27,393
2004-05-25	PHARMOS CORPS Sale	Director	SSale	−1,500 sh	$3.36	−$5,040	25,893
2004-05-25	PHARMOS CORPS Sale	Director	SSale	−6,305 sh	$3.35	−$21.1K	19,588
2004-05-25	PHARMOS CORPS Sale	Director	SSale	−6,898 sh	$3.33	−$23K	12,690
2004-05-25	PHARMOS CORPS Sale	Director	SSale	−5,795 sh	$3.32	−$19.2K	6,895
2004-05-25	PHARMOS CORPS Sale	Director	SSale	−1,895 sh	$3.38	−$6,405.1	5,000
2004-05-25	PHARMOS CORPS Sale	Director	SSale	−5,000 sh	$3.42	−$17.1K	0
2004-05-25	PHARMOS CORPStock OptionsM Exercise/Conversion	Director	MExercise/Conversion	−11.3K sh	—	—	3,750
2004-05-25	PHARMOS CORPStock OptionsM Exercise/Conversion	Director	MExercise/Conversion	−7,500 sh	—	—	2,500
2004-05-25	PHARMOS CORPStock OptionsM Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	5,000
2004-05-25	PHARMOS CORPStock OptionsM Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	10,000
2004-05-25	PHARMOS CORPStock OptionsM Exercise/Conversion	Director	MExercise/Conversion	−6,250 sh	—	—	13,750
2004-01-01	Aceragen, Inc.Stock OptionsA Award	Director	AAward	+3,750 sh	—	—	3,750
2003-10-01	Aceragen, Inc.Stock OptionsA Award	Director	AAward	+3,750 sh	—	—	3,750

Recent filings

Accepted (ET)
Feb 224
MARCEL GEORGES ANTHONY0001297596-05-000008
SEC(opens sec.gov)
May 274
MARCEL GEORGES ANTHONY0001290739-04-000002
SEC(opens sec.gov)

Companies

Address

C/O PHARMOS CORPORATION 99 WOOD AVENUE SOUTH, SUITE 311

ISELIN, NJ, 08830